Home Examinations Researching and Understanding Submucosal Evaluations

NCT05004870 | Withdrawn FDA Device

• 1 other identifier: 010
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

To demonstrate that imaging via home ultrasound can identify submucosal fibroids. The image quality and submucosal fibroid detection specificity of the home imaging has already been demonstrated; the aim of this study is to generate further data for sensitivity. This will be a single visit study, with participants scanning themselves at home with healthcare professional (HCP) supervision. Targeted population is women with previously diagnosed submucosal fibroids that have not been removed. The study will be single-blinded to the image raters.

Conditions

Fertility Issues

Outcome Measures

Primary Outcomes (1)

• Sensitivity of the at-home ultrasound for submucosal fibroids

  Qualified independent raters will be asked if they see a submucosal fibroid on the uterine videos. Answer options are: Yes, definitely; Almost certain; Possibly; Unlikely; No; N/A. In order to consider a fibroid present, either (1) two raters must answer "Almost certain" to having seen a submucosal fibroid or (2) one must answer "Yes definitely" to having seen a submucosal fibroid

  Up to 20 minutes

Study Arms (1)

Women with a known history of submucosal fibroids (that have not been surgically removed)

EXPERIMENTAL

Device: Transvaginal ultrasound performed by a woman herself (with HCP supervision via telemedicine)

Interventions

Transvaginal ultrasound performed by a woman herself (with HCP supervision via telemedicine) DEVICE

The ultrasound device used is cleared for HCP-supervised use in environments where healthcare is provided by trained HCPs. No changes to the design or manufacture have been made for this study.

Women with a known history of submucosal fibroids (that have not been surgically removed)

Eligibility Criteria

• Age: 18 Years - 49 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Women with one or more submucosal fibroid, with appropriate attestation (see more detail below)
• Women between the ages of 18 and 49 inclusive (women 38 and younger can also receive their antral follicle count, or AFC; 39 and older will participate in uterine scanning only)
• Women with BMI up to 40
• Women located in states where the PI or sub-PI licensure is valid
• Women able to freely give consent electronically, given COVID. For the purposes of this study, this is defined as women who speak native or fluent English; and have a high school degree or equivalent, and who are otherwise, in the professional judgement of the PI, able to give informed consent

You may not qualify if:

• Women with expert ultrasound experience, e.g., ultrasound technologists, radiologists, OB/GYNs, Reproductive Endocrinologists
• Women with BMI over 40
• Women who do not speak English natively or fluently
• Women who have recently given birth, and have had fewer than 3 postpartum menstrual cycles
• Women who have recently had a stillbirth or abortion more than 20 weeks (subject to the 3 postpartum menstrual cycles above). Miscarriages or abortions less than 20 weeks are subject to two wait cycles
• Women who are currently pregnant or may be pregnant
• Any woman the PI believes is not capable of giving independent, informed consent
• Turtle Health employees

Sponsors & Collaborators

• Turtle Health, Inc.: lead

Study Sites (1)

Virtual metasite

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital Diseases; Urogenital Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 6, 2021
• First Posted: August 13, 2021
• Study Start: December 16, 2021
• Primary Completion: December 17, 2021
• Study Completion: December 17, 2021
• Last Updated: April 29, 2022

Record last verified: 2022-04

Locations

US (1)